- 询价
- MP
- 0219916101
- 进口
- 2025年07月13日
企业认证
相关产品推荐更多 >
![EFNA1 Monoclonal Antibody [3C6] (100 ug), EFNA1单克隆抗体[3C6] (100 ug)](https://custom.dxycdn.com/trademd/upload/pic/2009/09/30/1254281266.gif!small.t.1)
EFNA1 Monoclonal Antibody [3C6] (100 ug), EFNA1单克隆抗体[3C6] (100 ug)
￥6208EpiQuik Global Acetyl Histone H3K9 Quantification Kit (Fluorometric) (48 assays), 通用乙酰化组蛋白H3K9定量分析试剂盒(荧光法)(48次分析)
￥3936UNIVERSAL REPIPET II DISPENSOR
询价PIAS2 Monoclonal Antibody [1F7] (100 ug), PIAS2单克隆抗体[1F7] (100 ug)
￥6208PROTHROMBINPOLYCLONAL ANTIBODY
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 供应商：
西宝生物
- 英文名：
SIMA 4D3 CANCER MARKER
- 保存条件：
ROOM TEMPERATURE
- 库存：
1 µg
- 规格：
BIOCHEMICALS
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Mutagen-Induced Chromatid Breakage as a Marker of Cancer Risk
Risk assessment is now recognized as a multidisciplinary process, extending beyond the scope of traditional epidemiologic methodology to include biological evaluation of interindividual differences in carcinogenic susceptibility. Modulation
the clinical usefulness of urinary β-CF as a tumor marker for nontrophoblastic tumors ( 5 , 6 ). Here, the authors describe the methods to measure urinary β-CF in patients with ovarian cancer. Fig. 1. Two antigenic sites: the first domain
complexes. Therefore, MHC antigens may serve as potential biomarkers for prognosis and allow selection of cancer patients for specific therapy. We describe PCR-based method to determine the HLA genotype in healthy individuals and patients using blood
技术资料暂无技术资料 索取技术资料
